Description

Soliqua is a prescription medication that combines insulin glargine and lixisenatide, used to improve glycemic control in adults with type 2 diabetes. It is administered via subcutaneous injection and is typically used when diet and exercise alone do not provide adequate control.

Interpreter Notes

Interpreters should be aware that 'Soliqua' may be referred to by its components, insulin glargine and lixisenatide, in some contexts. It is important to maintain a formal register and avoid colloquial terms. Stick to the term 'Soliqua' in clinical discussions to prevent confusion.

Example Sentences

EN: The doctor prescribed Soliqua to help manage the patient's blood sugar levels.

ES: El médico recetó Soliqua para ayudar a controlar los niveles de azúcar en la sangre del paciente.

Common Interpreter Mistakes

Confusing Soliqua with other diabetes medications; mispronouncing 'lixisenatide' as 'lixisenatide'; using informal language when discussing the medication.